Container system for enabling commercial production of cryopreserved cell therapy products

Author： Woods Erik J   Bagchi Aniruddha   Goebel W Scott   Vilivalam Vinod D   Vilivalam Vinod D  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.5, Iss.4, 2010-07, pp. : 659-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1508-1514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1501-1507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterising intensity-modulated radiation therapy (IMRT) software following upgrades in a commercial treatment planning system

By  

Journal of Radiotherapy in Practice, Vol. 9, Iss. 4, 2010-11 ,pp. : 209-221

Cambridge University Press

Access to resources Recommend Favorite

Efficient system for secretory production of fibrinogen

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 315-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical limb ischemia: thrombogenic evaluation of two autologous cell therapy products and biologic profile in treated patients

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2692-2701

John Wiley & Sons Inc

Access to resources Recommend Favorite